Nunez, John-Jose http://orcid.org/0000-0002-1602-6382
Leung, Bonnie http://orcid.org/0000-0003-3319-8343
Ho, Cheryl
Ng, Raymond T.
Bates, Alan T. http://orcid.org/0000-0002-7377-1880
Article History
Received: 23 December 2023
Accepted: 28 March 2024
First Online: 8 April 2024
Competing interests
: The authors declare the following competing interests: J.J.N. reported receiving unrestricted grant funding from Pfizer Canada through the Pfizer Innovation Fund during the conduct of the study. B.L. reported receiving personal fees from AstraZeneca outside the submitted work. C.H. reported personal fees from AbbVie, Amgen Inc, Bayer AG, Bristol-Myers Squibb Company, Eisai Co, Ltd, Janssen Pharmaceuticals, Jazz Pharmaceuticals PLC, Merck & Co, Inc, Novartis AG, and Takeda Pharmaceutical Company Limited and grant funding from AstraZeneca, EMD Serono, and F. Hoffmann–La Roche AG outside the submitted work. A.T.B. reported receiving unrestricted grant funding from Pfizer Inc to BC Cancer allocated to the Psychiatry Department during the conduct of the study and participating on an advisory panel in 2019 for Eisai Co, Ltd, outside the submitted work. R.T.N. declares no competing interests.